CALA logo

Calithera Biosciences (CALA) Selling, General & Administrative Expenses

Annual SGA

$13.54 M
-$7.31 M-35.06%

December 31, 2022

Summary

Performance

1-Year Change

-35.06%

3-Year Change

-18.45%

5-Year Change

+8.07%

15-Year Change

+8.07%

CALA SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

31.44%
CALA annual SGA is higher than 31.44% of companies in Healthcare sector

High & Low

All-time High

$20.85 M
CALA annual SGA is currently -35.06% below its historical high of $20.85 million

3-Year Low

$13.54 M
CALA annual SGA is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2022
CALA previous annual earnings announcement was published on Dec 31, 2022

Next Annual Earnings Report Date

Feb 14, 2025
CALA next annual earnings announcement is scheduled for Feb 14, 2025

OtherCALAexpensesmetrics:

Annual Total Expenses

$42.07 M
CALA annual total expenses is $42.07 million

Annual Operating Expenses

$42.07 M
CALA annual total operating expenses is $42.07 million

Annual Cost Of Goods Sold

-
CALA annual cost of goods sold value is unknown

Annual Interest Expense

-
CALA annual interest expense value is unknown

Quarterly SGA

$2.58 M
-$495.00 K-16.08%

December 31, 2022

Summary

Performance

3-Month Change

-16.08%

1-Year Change

-39.34%

3-Year Change

-43.22%

5-Year Change

-21.7%

CALA Quarterly SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

21.95%
CALA quarterly SGA is higher than 21.95% of companies in Healthcare sector

High & Low

All-time High

$6.34 M
CALA quarterly SGA is currently -59.27% below its historical high of $6.34 million

3-Year Low

$2.58 M
CALA quarterly SGA is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Dec 31, 2022
CALA previous earnings announcement was published on Dec 31, 2022

Next Quarterly Earnings Report Date

Feb 14, 2025
CALA next earnings announcement is scheduled for Feb 14, 2025

OtherCALAexpensesmetrics:

Quarterly Total Expenses

$7.35 M
CALA quarterly total expenses is $7.35 million

Quarterly Operating Expenses

$7.35 M
CALA quarterly total operating expenses is $7.35 million

Quarterly Cost Of Goods Sold

-
CALA quarterly cost of goods sold value is unknown

Quarterly Interest Expense

-
CALA quarterly interest expense value is unknown

TTM SGA

-$2.02 B
-$21.29 M-1.07%

December 31, 2022

Summary

Performance

3-Month Change

-13085.24%

1-Year Change

-10358.24%

3-Year Change

-12261.01%

5-Year Change

-12261.01%

CALA TTM SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

23.7%
CALA TTM SGA is higher than 23.7% of companies in Healthcare sector

High & Low

All-time High

-$30.14 M

3-Year Low

-$2.02 B
CALA TTM SGA is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Dec 31, 2022
CALA previous earnings announcement was published on Dec 31, 2022

Next Quarterly Earnings Report Date

Feb 14, 2025
CALA next earnings announcement is scheduled for Feb 14, 2025

OtherCALAexpensesmetrics:

Annual Total Expenses

$42.07 M
CALA annual total expenses is $42.07 million

Annual Operating Expenses

$42.07 M
CALA annual total operating expenses is $42.07 million

TTM Cost Of Goods Sold

-
CALA TTM cost of goods sold value is unknown

TTM Interest Expense

-
CALA TTM interest expense value is unknown

Selling, General & Administrative Expenses Formula

SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development

Annual SGA

$13.54 M
CALA annual SGA is $13.54 million

Annual Operating Expenses

$42.07 M
CALA annual total operating expenses is $42.07 million

Annual Cost Of Goods Sold

-
CALA annual cost of goods sold value is unknown

CALA Selling, General & Administrative Expenses Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-35.1%-39.3%-10000.0%
3 y3 years-18.4%-43.2%-10000.0%
5 y5 years+8.1%-21.7%-10000.0%

CALA Selling, General & Administrative Expenses Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-35.1%at low-43.8%at low-17.3%at low
5 y5-year-35.1%at low-59.3%at low-99.0%at low
alltimeall time-35.1%+855.6%-59.3%+343.2%-6599.4%at low

Calithera Biosciences Selling, General & Administrative Expenses History

DateAnnualQuarterlyTTM
Dec 2022
$13.54 M(-35.1%)
$2.58 M(-16.1%)
$13.54 M(-12.9%)
Sep 2022
-
$3.08 M(-14.9%)
$15.55 M(-17.4%)
Jun 2022
-
$3.62 M(-15.1%)
$18.82 M(-4.4%)
Mar 2022
-
$4.26 M(-7.3%)
$19.68 M(-5.6%)
Dec 2021
$20.85 M(+2.4%)
$4.59 M(-27.6%)
$20.85 M(-4.5%)
Sep 2021
-
$6.34 M(+41.4%)
$21.84 M(+7.9%)
Jun 2021
-
$4.49 M(-17.3%)
$20.25 M(-2.9%)
Mar 2021
-
$5.43 M(-2.8%)
$20.85 M(+2.4%)
Dec 2020
$20.37 M(+22.7%)
$5.59 M(+17.7%)
$20.37 M(+5.4%)
Sep 2020
-
$4.74 M(-6.9%)
$19.34 M(+4.5%)
Jun 2020
-
$5.10 M(+3.0%)
$18.50 M(+6.4%)
Mar 2020
-
$4.95 M(+8.7%)
$17.39 M(+4.7%)
Dec 2019
$16.61 M(+24.5%)
$4.55 M(+16.5%)
$16.61 M(+8.5%)
Sep 2019
-
$3.91 M(-2.0%)
$15.30 M(+5.7%)
Jun 2019
-
$3.98 M(-4.3%)
$14.48 M(+3.5%)
Mar 2019
-
$4.16 M(+28.2%)
$14.00 M(+4.9%)
Dec 2018
$13.34 M
$3.25 M(+5.2%)
$13.34 M(-0.4%)
Sep 2018
-
$3.09 M(-11.7%)
$13.39 M(+0.1%)
Jun 2018
-
$3.50 M(-0.3%)
$13.38 M(+5.1%)
DateAnnualQuarterlyTTM
Mar 2018
-
$3.51 M(+6.3%)
$12.73 M(+1.6%)
Dec 2017
$12.53 M(+18.4%)
$3.30 M(+7.4%)
$12.53 M(+2.4%)
Sep 2017
-
$3.07 M(+7.9%)
$12.24 M(+6.6%)
Jun 2017
-
$2.85 M(-13.9%)
$11.49 M(+1.6%)
Mar 2017
-
$3.31 M(+9.9%)
$11.30 M(+6.8%)
Dec 2016
$10.59 M(+16.7%)
$3.01 M(+29.8%)
$10.59 M(+7.3%)
Sep 2016
-
$2.32 M(-13.0%)
$9.87 M(+1.2%)
Jun 2016
-
$2.67 M(+2.9%)
$9.75 M(+3.4%)
Mar 2016
-
$2.59 M(+12.9%)
$9.43 M(+3.9%)
Dec 2015
$9.07 M(+69.4%)
$2.29 M(+4.4%)
$9.07 M(+5.0%)
Sep 2015
-
$2.20 M(-6.1%)
$8.64 M(+10.9%)
Jun 2015
-
$2.34 M(+4.6%)
$7.79 M(+15.3%)
Mar 2015
-
$2.24 M(+19.9%)
$6.76 M(+26.2%)
Dec 2014
$5.35 M(+116.1%)
$1.87 M(+38.5%)
$5.35 M(+19.5%)
Sep 2014
-
$1.35 M(+2.9%)
$4.48 M(+20.6%)
Jun 2014
-
$1.31 M(+57.3%)
$3.72 M(+54.4%)
Mar 2014
-
$832.00 K(-16.1%)
$2.41 M(+52.8%)
Dec 2013
$2.48 M(+74.9%)
$992.00 K(+70.2%)
$1.57 M(+170.2%)
Sep 2013
-
$583.00 K
$583.00 K
Dec 2012
$1.42 M
-
-

FAQ

  • What is Calithera Biosciences annual SGA?
  • What is the all time high annual SGA for Calithera Biosciences?
  • What is Calithera Biosciences annual SGA year-on-year change?
  • What is Calithera Biosciences quarterly SGA?
  • What is the all time high quarterly SGA for Calithera Biosciences?
  • What is Calithera Biosciences quarterly SGA year-on-year change?
  • What is Calithera Biosciences TTM SGA?
  • What is the all time high TTM SGA for Calithera Biosciences?
  • What is Calithera Biosciences TTM SGA year-on-year change?

What is Calithera Biosciences annual SGA?

The current annual SGA of CALA is $13.54 M

What is the all time high annual SGA for Calithera Biosciences?

Calithera Biosciences all-time high annual SGA is $20.85 M

What is Calithera Biosciences annual SGA year-on-year change?

Over the past year, CALA annual SGA has changed by -$7.31 M (-35.06%)

What is Calithera Biosciences quarterly SGA?

The current quarterly SGA of CALA is $2.58 M

What is the all time high quarterly SGA for Calithera Biosciences?

Calithera Biosciences all-time high quarterly SGA is $6.34 M

What is Calithera Biosciences quarterly SGA year-on-year change?

Over the past year, CALA quarterly SGA has changed by -$1.68 M (-39.34%)

What is Calithera Biosciences TTM SGA?

The current TTM SGA of CALA is -$2.02 B

What is the all time high TTM SGA for Calithera Biosciences?

Calithera Biosciences all-time high TTM SGA is -$30.14 M

What is Calithera Biosciences TTM SGA year-on-year change?

Over the past year, CALA TTM SGA has changed by -$2.04 B (-10358.24%)